BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19554454)

  • 1. Exploring the potential of a highly compressible microcrystalline cellulose as novel tabletting excipient in the compaction of extended-release coated pellets containing an extremely water-soluble model drug.
    Zeeshan F; Peh KK; Tan YT
    AAPS PharmSciTech; 2009; 10(3):850-7. PubMed ID: 19554454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of a novel modified-release pellet-based tablet system for the delivery of loratadine and pseudoephedrine hydrochloride as model drugs.
    Zeeshan F; Bukhari NI
    AAPS PharmSciTech; 2010 Jun; 11(2):910-6. PubMed ID: 20496016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
    Hosseini A; Körber M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compression of pellets coated with various aqueous polymer dispersions.
    Dashevsky A; Kolter K; Bodmeier R
    Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
    Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
    Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets.
    Kucera SU; DiNunzio JC; Kaneko N; McGinity JW
    Drug Dev Ind Pharm; 2012 Mar; 38(3):341-50. PubMed ID: 21870908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compression of controlled-release pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Dietzsch C; McGinity JW
    Pharm Dev Technol; 2005; 10(1):133-9. PubMed ID: 15776821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-solid interactions. IV. Influence of moisture sorption on the compaction of film-coated particles.
    Stubberud L; Eriksson M; Kordnejad K; Graffner C
    Pharm Dev Technol; 1998 May; 3(2):141-51. PubMed ID: 9653751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanistic understanding of compression damage to the dissolubility of coated pellets in tablets.
    Hiew TN; Tian YH; Tan HM; Heng PWS
    Eur J Pharm Biopharm; 2020 Jan; 146():93-100. PubMed ID: 31786321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
    Tian L; Zhang Y; Tang X
    Drug Dev Ind Pharm; 2008 Jun; 34(6):569-76. PubMed ID: 18568906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the coat quality of sustained release pellets by individual pellet dissolution methodology.
    Xu M; Liew CV; Heng PWS
    Int J Pharm; 2015 Jan; 478(1):318-327. PubMed ID: 25435182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro behavior of dronedarone hydrochloride loaded pellets using vacuum impregnation technique.
    Gretić M; Štanfel M; Barbarić J; Rimac N; Matijašić G
    Eur J Pharm Biopharm; 2021 May; 162():70-81. PubMed ID: 33727144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M; Newton M; Booth S; Clarke A
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the direct compression aid Ludiflash(®) for the preparation of pellets via wet extrusion/spheronization.
    Roblegg E; Schrank S; Griesbacher M; Radl S; Zimmer A; Khinast J
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1231-43. PubMed ID: 21438702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.